Literature DB >> 1734066

Immune reactivity to fractionated Leishmania aethiopica antigens during coinfection with human immunodeficiency virus type 1.

S C Arya.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1992        PMID： 1734066      PMCID： PMC265038          DOI： 10.1128/jcm.30.1.259-260.1992

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


× No keyword cloud information.
  16 in total

1.  Leishmaniasis in France.

Authors:  D Jeannel; P Tuppin; G Brucker; M Danis; M Gentilini
Journal:  Lancet       Date:  1989-09-30       Impact factor: 79.321

2.  Disseminated-to-skin kala-azar and the acquired immunodeficiency syndrome.

Authors:  M Yebra; J Segovia; L Manzano; J A Vargas; L Bernaldo de Quirós; J Alvar
Journal:  Ann Intern Med       Date:  1988-03       Impact factor: 25.391

3.  Visceral leishmaniasis in immunocompromised hosts.

Authors:  M L Fernández-Guerrero; J M Aguado; L Buzón; C Barros; C Montalbán; T Martín; E Bouza
Journal:  Am J Med       Date:  1987-12       Impact factor: 4.965

4.  Generation of species-specific DNA probes for Leishmania aethiopica.

Authors:  T Laskay; R Kiessling; T F Rinke deWit; D F Wirth
Journal:  Mol Biochem Parasitol       Date:  1991-02       Impact factor: 1.759

5.  Differential recognition of Leishmania aethiopica antigens by lymphocytes from patients with local and diffuse cutaneous leishmaniasis. Evidence for antigen-induced immune suppression.

Authors:  H O Akuffo; T E Fehniger; S Britton
Journal:  J Immunol       Date:  1988-10-01       Impact factor: 5.422

6.  Serum antibody specificities to Leishmania aethiopica antigens in patients with localized and diffuse cutaneous leishmaniasis.

Authors:  G Mengistu; H O Akuffo; T Yemane-Berhan; S Britton; T E Fehniger
Journal:  Parasite Immunol       Date:  1990-09       Impact factor: 2.280

7.  Immune responses to fractionated cytomegalovirus (CMV) antigens after HIV infection. Loss of cellular and humoral reactivity to antigens recognized by HIV-, CMV+ individuals.

Authors:  P J Converse; T E Fehniger; A Ehrnst; O Strannegård; S Britton
Journal:  Clin Exp Immunol       Date:  1990-12       Impact factor: 4.330

Review 8.  Visceral leishmaniasis in HIV infection and AIDS: clinical features and response to therapy.

Authors:  B S Peters; D Fish; R Golden; D A Evans; A D Bryceson; A J Pinching
Journal:  Q J Med       Date:  1990-11

9.  Visceral leishmaniasis in patients infected with human immunodeficiency virus. Co-operative Group for the Study of Leishmaniasis in AIDS.

Authors:  C Montalban; J L Calleja; A Erice; F Laguna; B Clotet; D Podzamczer; J Cobo; J Mallolas; M Yebra; A Gallego
Journal:  J Infect       Date:  1990-11       Impact factor: 6.072

10.  Immune reactivity to fractionated Leishmania aethiopica antigens during active human infection.

Authors:  T Laskay; H G Mariam; T Y Berhane; T E Fehniger; R Kiessling
Journal:  J Clin Microbiol       Date:  1991-04       Impact factor: 5.948
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.